Medsn Launches Global Learning Program for Worldwide Product Launch of Recently FDA-Approved HIV/AIDS Drug Business Wire
click here to return to Business Wire main menu
DonateNow
Print this Article


Medsn Launches Global Learning Program for Worldwide Product Launch of Recently FDA-Approved HIV/AIDS Drug

Business Wire - June 24, 2003


MORRISTOWN, N.J.-- Medsn Inc.: Utilizing 2D and 3D Animation, Medsn Demonstrates Mechanism of Action and Complexity of Compound for a New HIV Drug to Support Product Launch Initiatives Designed for Sales Specialists, Marketing and Medical Affairs Personnel, MDs, RNs, and Other Healthcare Providers

Medsn Inc., the premier interactive medical education and marketing company, today announced the successful launch of a new and innovative medical education tool applicable to global product launches. On behalf of a major pharmaceutical enterprise based on the East Coast, Medsn created a multimedia, integrated Global Learning Program. The components included print materials, interactive patient cases on CD-ROM, a collection of 2D and 3D animation, and video. The Program was created to educate customers and train a worldwide sales and marketing group for this important product launch.

The Medsn Global Learning Program successfully animated the mechanism of action of the new product, the complexity of the compound, and its unique clinical profile compared to a variety of other medications. In DVD and video format, Medsn provided the pharmaceutical company with the opportunity to provide consistent and high-impact representation to its vast and diverse audience. Additionally, Medsn provided an interview with the primary researcher and developer of the new drug.

"The genesis of this educational program was a need to depict the complex mechanism in a manner that was medically accurate, captivating, complete, and appropriate for the entire range of clinical audiences in addition to the many departments within the organization's medical and marketing infrastructure," stated Dennis Bonilla, CEO of Medsn.

Destry Sulkes, MD, MBA and Managing Director of Medsn, Eastern Region, added, "Medsn is proud that our model of 'doctors-teaching-doctors' was a great match for this key medical advance in HIV -- our expert medical staff and creative team partnered with our client's teams and delivered a highly engaging learning experience for all audiences who need this new information to benefit patients."

About Medsn

Medsn is a premier medical education and marketing company that designs and implements customized, interactive educational programs for pharmaceutical, medical device, biotechnology, and healthcare organizations. Medsn focuses exclusively on healthcare and employs an in-house staff of physicians, marketing experts, industry executives, medical illustrators, and technology specialists who possess unique expertise in effectively leveraging interactive multimedia technologies with traditional educational methodologies to develop high-impact programs that influence the behavior of physicians, healthcare professionals, and patients, as well as pharmaceutical and medical device sales representatives.

Medsn is recognized within the healthcare industry for its in-depth medical and life sciences domain knowledge, state-of-the-art learning platform, and proven expertise in client services. Medsn delivers ROI through efficient, effective behavior-changing solutions.

The company is supported by key academic advisors at premier institutions, including Yale, Johns Hopkins, UC San Francisco, Oxford, and Cambridge, as well as leading experts in the fields of sales and marketing, communications and learning.

CONTACT: DeMonte Associates Cynthia DeMonte, 212/605-0525 (Media/Investors) cdemonte@demonte.com

SOURCE: Medsn Inc.


030624
BW030607


Copyright © 2003 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .